Eve Health Group Share Price and Company Fundamentals



Price
$0.018
Change
0.000 (0.000%)
52 week range
0.014 - 0.036

Last traded: Last Wednesday at 11:59 PM

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property). Its lead product is the Dyspro, a formulation developed to address dysmenorrhoea and Endometriosis Pain; and Libbo, an oral dissolving film for erectile dysfunction. The company also develops Apixaban to treat anticoagulation. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

Key Metrics

PE ratio

-

PB ratio

1.64

Dividend yield

-

Beta

0.45

Market cap

$6.34M

Enterprise value

$5.10M

Company profile

Industry / Sector Packaged Foods / Consumer Defensive
Website https://www.evehealthgroup.com.au
Mailing address 245 Churchill Avenue Suite 1 Subiaco WA 6008 Australia
Phone / Fax 61 8 6465 5500 /

Dividends

More: Eve Health Group Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Eve Health Group paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EVE dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Sep 2026, following are the company executives and directors listed on Eve Health Group.

Name Title Age Total Pay
Mr. Benedict James Rohr Chief Operating Officer
Dr. Stuart Gunzburg CSO & Executive Director
Mr. Steven Luke Jackson BEc, C.P.A. CFO & Company Secretary
Rebecca Bak Marketing Manager

Profitability and management effectiveness

Profit margin

-163.97%

Operating margin

-201.63%

Return on assets

-28.27%

Return on equity

-50.42%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Eve Health Group is 6.34M and its enterprise value is 5.10M. The enterprise value to revenue ratio of EVE is 4.43. The enterprise value to EBITDA ratio of EVE is -2.89.

The EVE's stocks Beta value is 0.45 making it 55% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Eve Health Group (EVE)

Eve Health Group (ASX:EVE) Frequently Asked Questions

1. What is Eve Health Group's Stock Symbol?

Eve Health Group trades on ASX under the ticker symbol "EVE".

2. What is Eve Health Group's stock price today?

One share of EVE stock can currently be purchased for approximately $0.018.

3. How can I contact Eve Health Group?

Eve Health Group's mailing address is 245 Churchill Avenue Suite 1 Subiaco WA 6008 Australia. The company can be reached via phone at 61 8 6465 5500.

4. What is Eve Health Group's official website?

The official website of Eve Health Group is https://www.evehealthgroup.com.au.